Aims-To study the geographical variation of the prevalence of hepatitis B virus (HBV) DNA in hepatitis B surface antigen (HBsAg) negative subjects. Methods-A nested polymerase chain reaction (PCR) assay was used to amplify the core region of HBV. 
were positive for HBV-DNA while none of the 70 cases from the United Kingdom was positive by nested PCR. Contamination by plasmid DNA was excluded using a novel method based on heteroduplex formation. One HBV-DNA positive case had idiopathic chronic active hepatitis, but the diagnoses in the other three HBV-DNA positive cases did not suggest any aetiological connection between HBV-DNA positivity and liver pathology. Conclusions-HBV-DNA could be detected in the liver tissues of a proportion of HBsAg negative subjects. The prevalence of such cases is related to the endemic rate of a geographical region. The use of HBV PCR on paraffin wax embedded tissues will be valuable for future studies on the molecular epidemiology of HBV. (7 Clin Pathol 1993; 46:304-308) Hepatitis B virus (HBV) infection is a major public health problem, with an estimated carrier population of over 200 million world wide.' Diagnosis used to be based solely on serology, but development of molecular biology has led to the generation of data inconsistent with conventional serology, such as the detection of HBV-DNA in a significant proportion of patients with hepatitis B surface antigen (HBsAg) negative chronic liver disease." Subsequently, however, other investigators failed to confirm these observations. 4 6 The development of the polymerase chain reaction (PCR)7 has allowed these studies to be repeated using a method with exquisite sensitivity.8 The use of the PCR, however, has not resolved the above controversy in that some investigators have succeeded in amplifying HBV-DNA from HBsAg negative individuals9"2 while others have failed to do so."3 One explanation might be differences in methodologies used by different laboratories, but another reason might be a geographical difference in HBV virology-the endemic rate.
To address this important question, we benefited from the ability of the PCR to amplify from paraffin wax embedded liver tissues"1 14 which can be transferred easily from country to country. We used a modification of the basic amplification system called nested PCR. This has been shown to be as sensitive as PCR followed by Southern blotting, and yet has the added advantages of being non-isotopic and rapid. ' were observed, contamination tracing back to pHBV130 could not be excluded.
Results

SENSITIVITY OF HBV PCR SYSTEM
To determine the sensitivity of the nested HBV PCR system, serial dilutions of a plasmid containing a full-length HBV insert (pHBV130)19 were made in water. After 40 cycles of first round PCR, a signal was visible in an ethidium stained gel for 105 molecules (fig 1) . After 25 cycles of second round PCR the detection limit was extended to the equivalent of 10 molecules (fig 1) . This sensitivity was similar to that previously reported by (8 5%) tested in the high incidence areas were therefore positive in the HBV PCR assay. In the low incidence area (United Kingdom) studied, none of the 70 cases studied was positive by nested PCR. These results were significant (p < 0-05; x2 = 3-86; degree of freedom = 1).
HETERODUPLEX FORMATION AS A MEANS TO EXCLUDE CONTAMINATION
We have already described a method to exclude contamination by cloned viral DNA using heteroduplex formation.20 If heteroduplexes are formed between the PCR product from a test case and that from the plasmid pHBV130, then plasmid contamination can be excluded. This procedure was done for each of the four HBsAg negative cases (two from Hong Kong, two from Italy) that produced a positive HBV PCR signal. In all cases heteroduplexes with different mobility patterns were observed (fig 4) , thus confirming the validity of the results.
Discussion
The nested PCR system used was sensitive, rapid, and completely non-isotopic. The sensitivity of the method was such that 10 that HBV DNA could be detected in a proportion of HBsAg negative subjects.9-12 Furthermore, the proportion of such cases seems to be related to the endemic rate of HBV infection in a geographical region. Thus in high incidence areas such as Milan and Hong Kong, with a carrier rate of 3.5%22 and 9.6%,23 respectively, the percentages of HBV DNA positive cases were 11% and 6-9%, respectively. The HBsAg positive carrier rate in London has been estimated at 0Q5%24 and the carrier rate in Oxford is likely to be much lower. We have not been able to detect any HBV DNA in any of the 70 cases from the United Kingdom. It should be noted that our figures for HBV DNA positivity in Milan and Hong Kong should be regarded as gross estimates because the numbers involved are too small to provide a precise figure on the prevalence. Nevertheless, the difference in HBV DNA prevalence between the high and low incidence areas is highly significant. The commercially available tests for HBsAg used in this study were radioimmunoassay or ELISA based and these assays had a sensitivity of < 0-5 ng/ml.25 In a direct comparison between the three assays, the ELISA made by Biokit was not as sensitive as the radioimmunoassay and ELISA manufactured by Abbott Laboratories (Dr J Kurtz, John Radcliffe Hospital, personal communication). The assay used in Oxford would therefore bias our results in that we may have missed some cases with low concentrations of HBsAg. Hence the observation that none of the Oxford cases was positive by PCR is highly significant.
Our data, however, did not provide conclusive evidence of an aetiological link between HBV DNA positivity and the liver pathology seen. Interestingly, one Italian case diagnosed as having idiopathic chronic active hepatitis was shown to have HBV DNA by nested PCR. HBV could potentially have been the cause of liver pathology in this case. However, for the other three cases (porphyria cutanea tarda, secondary adenocarcinoma, and non-specific changes), the role of HBV was less clear. Nevertheless, these data show that HBV is present in a proportion of HBsAg negative subjects which may have public health implications in high incidence areas.
Some investigators have used multiple primer sets for HBV detection by PCR"'; others have used only one set of primers.'2 The use of multiple primer sets might increase the detection rate of HBV-DNA in our samples, but we do not think that this will alter our basic conclusions. Our belief is based on the relatively large sample size of our study (117 cases in total) and the fact that the primer combination we used has been used before to detect HBV DNA in HBsAg negative subjects." 12 Finally, the heteroduplex method20 we used to exclude contamination due to cloned viral DNA has been confirmed to be reliable and rapid. The differences in mobility of heteroduplexes from different cases shown in fig 4 were consistent with a previous report showing a 2-15% difference in nucleotide sequence in the core gene amplified from different HBV isolates.'2 We envisage that this method could be widely applied in many virological laboratories. Furthermore, the method could potentially be modified for typing viruses.
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